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*MD, ChH, AC and DS* conceived of the study. *MD, ChH, AC, DS, BV,* initiated the study design and *CP* helped with implementation. *CP* and *CJ* provided statistical expertise in clinical trial design. *GP* and *ME* provided imaging expertise*.DS* and *DS* provided the viral expertise. *MD, ChH, JH, CaH* and *WEB* carried out the olfactory tests and refined the questionnaires. *DA* and *PH* supervised the project. All authors contributed to refinement of the study protocol and approved the final manuscript.

The study is funded by the French Department of Health (Innovarc). Funding for this trial covers the run-in costs (clinical and paraclinicals examinations, treatments, data exploitation.

Each investigator will have access to the final trial dataset. Project data sets are housed on the Project Accept Web site (Clinfile), and all data sets are password protected. Project Principal Investigators have direct access to their own site's data sets. To ensure confidentiality, data dispersed to project team members will be blinded of any identifying participant information data will be available from the author on reasonable request (mdaval\@for.paris).

ANSM and CPP approved the study.

MEDAECNAT-2020-04-00075 approval was granted on May 14, 2020 .

CPP SUD EST II (2020-39) approval was granted on April 24, 2020. An amendment was accepted on June 3, 2020 to allow the inclusion of patients with persistent hyposmia up to 90 days after the onset of signs of COVID.

We declare that we certify that this trial has received ethical approval from the appropriate ethical committee described above. Each participant has to read an information note and signed a consent form for participation.
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